Adolphus Busch IV Supports Medical Marijuana in Missouri

The Relative of Adolphus Busch Believes that Medical Marijuana May Be the Solution to the Opioid Crisis

Adolphus Busch the IV is a family member of the Anheuser-Busch Company, the massive beer company that was sold back in 2008, but he still has influence in Missouri. He believes medical marijuana is important enough to write a letter urging legalized medical cannabis to be added to the ballot. There is a lot of speculation as to whether marijuana can battle the opioid crisis, which Missouri is contending with as well. Do you agree with Adolphus Busch the IV that marijuana may be the solution to the opioid epidemic?

There was a bit of backlash against a member of the Busch family for his support of medical marijuana in Missouri. Fox 2 confirmed that Adolphus Busch IV sent out a letter Friday and another a week earlier. They urge people to donate to the effort to gather signatures to put the issue before voters on the November 2018 ballot. The National Council on Alcoholism and Drug Abuse (NCADA) doesn’t like it.

Mr. Busch’s letter paints medical marijuana as a solution to the opioid crisis now gripping Missouri and the rest of the country.

“There’s a lot of messaging that’s been very simplified like this letter…saying that if we support this initiative then we can solve the opioid crisis,” said Stacie Zellin of NCADA.  “There are absolutely risks,   one of the biggest being dependency and/or addiction.”

Busch wrote the letter for the “pro” medical marijuana group New Approach Missouri.

The group points to a study showing opioid overdose deaths were down more than 25%  in states where medical marijuana has been legalized.

Busch’s letter claims 68% of Missourians support legalization for medical use.

Talk show host Montel Williams – who suffers from Multiple Sclerosis — is among those who’ve urged Missouri lawmakers to legalize medical marijuana in recent years.

The NCADA is not against using marijuana as medicine but wants it handled like a pharmaceutical with clinical trials and FDA approval before products go market.

In the NCADA’s view, Mr. Busch’s letter carries an air of commercialization.

“One of the largest concerns is who it’s coming from.  This is someone who benefitted from the profits of the alcohol industry,” Zellin said.  “You go into a dispensary.  You don’t go into a pharmacy.  This is also not prescribed to you by a doctor.  You get a note that it is recommended to you…then when you do walk into a dispensary, there isn’t that reliability in terms of product you’re getting, in terms of dosage, or what the different chemicals are in it…that’s a huge problem we’re seeing out in Colorado.  There’s products in these dispensaries that have THC  levels up to 70-80%.  That’s the part of marijuana that also causes damage to the brain.”

A spokesman for him said Busch had no commercial or economic interest in the issue.  The letters went out to be about 70 people, he said.

Read more…

Show More

Brian Wroblewski

Brian Wroblewski has a passion for writing, travel, food and family. Since working in and around the cannabis industry since 2008, Brian brings a unique perspective to the cannabis journalism space. With a focus on emerging brands, moving the cannabis industry forward and an undeniable passion for truth in business and journalism, find some of Brian's posts across the web on digital marketing, cannabis and a variety of different topics.

Related Articles

Back to top button